Homologous restriction factorZALMAN, L. S.Current Topics in Microbiology and Immunology. 1992, Vol 178, pp 87-99, issn 0070-217XArticle

Dimeric porin from Paracoccus denitrificansZALMAN, L. S; NIKAIDO, H.Journal of bacteriology. 1985, Vol 162, Num 1, pp 430-433, issn 0021-9193Article

Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complementZALMAN, L. S; MUÊLLER-EBERHARD, H. J.Molecular immunology. 1990, Vol 27, Num 6, pp 533-537, issn 0161-5890, 5 p.Article

Characterization of the insertion of Pseudomonas exotoxin A into membranesZALMAN, L. S; WISNIESKI, B. J.Infection and immunity. 1985, Vol 50, Num 3, pp 630-635, issn 0019-9567Article

Homologous restriction factor : effect on complement C8 and C9 uptake and lysisZALMAN, L. S; MÜLLER-EBERHARD, H.Molecular immunology. 1994, Vol 31, Num 4, pp 301-305, issn 0161-5890Article

Porin from Rhodopseudomonas sphaeroidesWECKESSER, J; ZALMAN, L. S; NIKAIDO, H et al.Journal of bacteriology. 1984, Vol 159, Num 1, pp 199-205, issn 0021-9193Article

Mechanism of insertion of diphtheria toxin: peptide entry and pore size determinationsZALMAN, L. S; WISNIESKI, B. J.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1984, Vol 81, Num 11, pp 3341-3345, issn 0273-1134Article

Isolation of a human erythrocyte membrane protein capable inhibiting expression of homologous complement transmembrane channelsZALMAN, L. S; WOOD, L. M; MULLER-EBERHARD, H. J et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 18, pp 6975-6979, issn 0027-8424Article

Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granulesZALMAN, L. S; BROTHERS, M. A; MULLER-EBERHARD, H. J et al.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 13, pp 4827-4831, issn 0027-8424Article

Inhibition of cytolytic lymphocytes by homologous restriction factor : lack of species restrictionZALMAN, L. S; BROTHERS, M. A; STRAUSS, K. L et al.The Journal of immunology (1950). 1991, Vol 146, Num 12, pp 4278-4281, issn 0022-1767, 4 p.Article

Induction of expression of cell-surface homologous restriction factor upon anti-CD3 stimulation of human peripheral lymphocytesMARTIN, D. E; ZALMAN, L. S; MÜLLER-EBERHARD, H. J et al.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 1, pp 213-217, issn 0027-8424Article

Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranesZALMAN, L. S; WOOD, L. M; MÜLLER-EBERHARD, H. J et al.The Journal of experimental medicine. 1987, Vol 166, Num 4, pp 947-955, issn 0022-1007Article

The cytolytic protein of human lymphocytes related to the ninth component (C9) of human complement: isolation from anti-CD3-activated peripheral blood mononuclear cellsZALMAN, L. S; MARTIN, D. E; JUNG, G et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 8, pp 2426-2429, issn 0027-8424Article

Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitorZALMAN, L. S; BROTHERS, M. A; DRAGOVICH, P. S et al.Antimicrobial agents and chemotherapy. 2000, Vol 44, Num 5, pp 1236-1241, issn 0066-4804Article

Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitorBINFORD, S. L; MALDONADO, F; BROTHERS, M. A et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 2, pp 619-626, issn 0066-4804, 8 p.Article

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuriaZALMAN, L. S; WOOD, L. M; FRANK, M. M et al.The Journal of experimental medicine. 1987, Vol 165, Num 2, pp 572-577, issn 0022-1007Article

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitorsDRAGOVICH, P. S; RU ZHOU; MEADOR, J. W et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 1, pp 45-48, issn 0960-894XArticle

In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C proteasePATICK, A. K; BINFORD, S. L; FUHRMAN, S. A et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 10, pp 2444-2450, issn 0066-4804Article

Comparison of human cytomegalovirus (HCMV) protease sequences among laboratory strains and seven clinical isolatesHUFFAKER, T. K; BINFORD, S; PATICK, A. K et al.Antiviral research. 1997, Vol 33, Num 3, pp 215-218, issn 0166-3542Article

Induction of synthesis of the cytolytic C9 (ninth component of complement)-related protein in human peripheral mononuclear cells by monoclonal antibody OKT3 or interleukin 2: correlation with cytotoxicity and lymphocyte phenotypeMARTIN, D. E; ZALMAN, L. S; GUNDRAM JUNG et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 9, pp 2946-2950, issn 0027-8424Article

Mechanism of cytotoxicity of human large granular lymphocytes: relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complementZALMAN, L. S; BROTHERS, M. A; CHIU, F. J et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 14, pp 5262-5266, issn 0027-8424Article